Iterative Health has appointed Bill Kayser as its new President and CFO, marking a major hire as the company pushes to expand its role in GI clinical research. Kayser, who most recently led finances at GI Alliance before its acquisition by Cardinal, brings deep expertise in physician group strategy, M&A, and scaling healthcare organizations. His background—spanning investment banking, Prospero Health (Optum), and McKesson—positions him to steer Iterative’s financial strategy at a time when clinical research and AI are reshaping how GI therapies reach patients.
Keep Reading
Add A Comment